Sequoia Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23M Sell
4,243
-458
-10% -$257K 0.01% 593
2026
Q1
$2.64M Buy
4,701
+716
+18% +$459K 0.01% 510
2025
Q4
$2.7M Buy
3,985
+748
+23% +$509K 0.02% 488
2025
Q3
$2.07M Buy
3,237
+543
+20% +$330K 0.01% 510
2025
Q2
$1.45M Buy
2,694
+757
+39% +$362K 0.01% 563
2025
Q1
$813K Buy
1,937
+252
+15% +$109K 0.01% 691
2024
Q4
$697K Buy
1,685
+98
+6% +$43K 0.01% 695
2024
Q3
$802K Sell
1,587
-2
-0.1% -$972 0.01% 607
2024
Q2
$774K Buy
1,589
+117
+8% +$58.7K 0.01% 556
2024
Q1
$795K Sell
1,472
-507
-26% -$277K 0.01% 536
2023
Q4
$1.1M Buy
1,979
+292
+17% +$137K 0.01% 497
2023
Q3
$738K Buy
1,687
+15
+0.9% +$7.48K 0.01% 407
2023
Q2
$840K Buy
1,672
+34
+2% +$16.3K 0.01% 382
2023
Q1
$819K Buy
1,638
+55
+3% +$26.3K 0.02% 355
2022
Q4
$646K Buy
1,583
+716
+83% +$278K 0.02% 377
2022
Q3
$282K Sell
867
-124
-13% -$45.5K 0.01% 399
2022
Q2
$348K Sell
991
-1
-0.1% -$408 0.01% 399
2022
Q1
$543K Buy
992
+134
+16% +$70.5K 0.01% 340
2021
Q4
$565K Buy
+858
New +$539K 0.02% 307
2021
Q3
– Sell
-716
Closed -$452K – 340
2021
Q2
$452K Buy
716
+4
+0.6% +$2.21K 0.02% 295
2021
Q1
$348K Buy
712
+25
+4% +$12.5K 0.01% 309
2020
Q4
$343K Buy
687
+5
+0.7% +$2.24K 0.02% 299
2020
Q3
$268K Sell
682
-25
-4% -$9.24K 0.01% 315
2020
Q2
$233K Buy
+707
New +$205K 0.01% 325

Other funds holding IDXX

Sequoia Financial Advisors's IDXX Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Idexx Laboratories (IDXX) stake by 9.7% in Q2 2026, selling an estimated $257K and leaving 4,243 shares worth $2.23M. The position accounts for 0.01% of the portfolio, ranked #593.

Sequoia Financial Advisors first reported a position in IDXX in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.7M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sequoia Financial Advisors held 4,243 shares of Idexx Laboratories worth $2.23M as of Q2 2026.
  • Sequoia Financial Advisors sold 458 Idexx Laboratories shares in Q2 2026, an estimated $257K.
  • Idexx Laboratories made up 0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #593 holding.
  • Sequoia Financial Advisors first reported a position in Idexx Laboratories in Q2 2020 and has held it in 24 quarters since.
  • Sequoia Financial Advisors's Idexx Laboratories position peaked at $2.7M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.